Pseudoscience and fraudulent products for COVID-19 management
- PMID: 35836045
- PMCID: PMC9282830
- DOI: 10.1007/s11356-022-21967-4
Pseudoscience and fraudulent products for COVID-19 management
Abstract
As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely throughout the world. Additionally, new variants of the mutated viral variants have been found in some countries that are more dangerous than the original strain. Even vaccines cannot produce complete protective immunity against the newer strains of SARS-CoV-2. Due to such a dreadful situation, lots of fear and depression have been created among the public. People are looking for the treatment of the disease at any cost and there is a race in the market to provide treatment and make money, whether it is effective or not! In such a condition, many fraud products, remedies, and myths have come into the market, which is falsely claimed to be effective for the disease and can harm the patients. Hence, FDA has banned such products and remedies. In this review, we have compiled all such fraudulent and pseudosciences identified for COVID-19. Currently, in the pandemic time, health agencies are approving the repurposed medicines based on the small-scale clinical data for emergency uses that become ineffective (most of the cases) after large randomized clinical studies. Proper vigilance strategies need to be defined by the regulatory agencies of the nation and routine awareness programs shall be arranged for educating the people and healthcare workers on routine updates.
Keywords: COVID-19; Fraudulent product; Myth; Pseudoscience; SARS-CoV-2; Vaccine.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.Elife. 2022 Feb 22;11:e75537. doi: 10.7554/eLife.75537. Elife. 2022. PMID: 35191378 Free PMC article.
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.Viruses. 2022 Nov 17;14(11):2541. doi: 10.3390/v14112541. Viruses. 2022. PMID: 36423150 Free PMC article. Review.
Cited by
-
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.Front Immunol. 2022 Oct 3;13:961198. doi: 10.3389/fimmu.2022.961198. eCollection 2022. Front Immunol. 2022. PMID: 36263030 Free PMC article. Review.
-
Recent review of COVID-19 management: diagnosis, treatment and vaccination.Pharmacol Rep. 2022 Dec;74(6):1120-1148. doi: 10.1007/s43440-022-00425-5. Epub 2022 Oct 10. Pharmacol Rep. 2022. PMID: 36214969 Free PMC article. Review.
-
Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19.Curr Pharm Des. 2022;28(46):3658-3670. doi: 10.2174/1381612829666221024124848. Curr Pharm Des. 2022. PMID: 36284382 Review.
-
I trust my immunity more than your vaccines: "Appeal to nature" bias strongly predicts questionable health behaviors in the COVID-19 pandemic.PLoS One. 2023 Feb 22;18(2):e0279122. doi: 10.1371/journal.pone.0279122. eCollection 2023. PLoS One. 2023. PMID: 36812237 Free PMC article.
-
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics.Vaccines (Basel). 2022 Dec 15;10(12):2150. doi: 10.3390/vaccines10122150. Vaccines (Basel). 2022. PMID: 36560560 Free PMC article. Review.
References
-
- Aday S, Aday MS. Impact of COVID-19 on the food supply chain. Food Qual Saf. 2020;4:167–180. doi: 10.1093/FQSAFE/FYAA024. - DOI
-
- Aleem A, Akbar Samad AB, Slenker AK (2022) Emerging variants of SARS-CoV-2 And novel therapeutics against coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Treasure Island (FL) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous